Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-030288

Options or other derivatives

  • Director acquired 44,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
JOHNSON DAVID LEE Director 2022-05-18 Grant or award · Option to purchase Common Stock +44,000 44,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…